诊断困境:药物诱导的血管炎与全身性血管炎
Indira Acharya1, David S Weisman2, Lanaya Williams Smith3
1Department of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.
BMJ case reports
|July 10, 2023
概括
药物诱导的血管炎虽然很少见,但会影响脏和肺组织. 这一案例突显了拉诱导的血管炎,呈现为肺综合征.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 类风湿病学 类风湿病学
- 病理学 病理学 病理学
背景情况:
- 药物诱导性血管炎是一种罕见的疾病,导致血管壁的炎症和亡.
- 由于系统性血管炎的临床,免疫和病理特征重叠,诊断具有挑战性.
- 组织活检对于诊断和治疗指导至关重要.
研究的目的:
- 为了呈现一种由拉诱导的血管炎病例.
- 为了说明药物诱导血管炎的诊断挑战和病理发现.
- 为了突出肺综合征的表现.
主要方法:
- 案例报告的呈现方式.
- 对临床表现,免疫学检查和病理发现的审查.
- 病理发现与临床信息的相关性.
主要成果:
- 这位患者呈现了拉诱导的抗中性粒细胞抗体-阳性血管炎.
- 这种情况表现为肺综合征.
- 病理学发现包括乳腺免疫性血球炎和气囊出血.
结论:
- 药物诱导的血管炎需要对临床和病理数据进行仔细的关联,以准确诊断.
- 拉可以诱导抗中性粒细胞抗体-阳性血管炎与肺干涉.
- 根据活检结果进行及时诊断和治疗至关重要.
相关概念视频
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
17
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17
Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Imaging Studies VII: Vascular Imaging
32
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
32


